HELP     Sign In
Search

Relevance to Autism

Neural microexons, many of which are regulated by the neuronal-specific splicing factor nSR100/SRRM4, were found to be frequently dysregulated in the brains of individuals with ASD; this dysregulation was associated with reduced levels of nSR100 (Irimia et al., 2014). nSR100/Srrm4 haploinsufficiency in mice resulted in misregulated splicing patterns, autistic features such as sensory hypersensitivity and altered social behavior, and impaired synaptic transmission and excitability (Quesnel-Vallieres et al., 2016).

Molecular Function

SRRM4 promotes alternative splicing and inclusion of neural-specific exons in target mRNAs. This splicing factor is specifically required for neural cell differentiation.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
A highly conserved program of neuronal microexons is misregulated in autistic brains.
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
Large-scale discovery of novel genetic causes of developmental disorders.
Unknown diagnosis
Support
A global regulatory mechanism for activating an exon network required for neurogenesis.
Support
Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis.
Recent Recommendation
Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN671R001 
 missense_variant 
 c.217G>A 
 p.Gly73Ser 
 De novo 
  
 Unknown 
 GEN671R002 
 splice_region_variant 
 c.515+6T>C 
  
 De novo 
  
  
 GEN671R003 
 missense_variant 
 c.1640G>A 
 p.Arg547His 
 De novo 
  
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
12
Duplication
 1
 
12
Duplication
 3
 
12
Deletion-Duplication
 5
 
12
Duplication
 1
 

Model Summary

nSR100/SRRM4 haplo-insufficient mice with reduced levels of the neuronal splicing regulator protein (SRRM4) and decreased levels of the components of its target splicing program display neurodevelopmental defects and altered synaptic transmission, neuronal excitability, social behaviors, synaptic density and signaling, in a sexually dimorphic manner.

References

Type
Title
Author, Year
Primary
Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.

M_SRRM4_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Mice harboring a homozygous frameshift deletion mutation spanning exons 7 and 8 of the SRRM4 gene.
Allele Type: Targeted
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: Unreported
Mutant ES Cell Line: Unreported
Model Source: Unreported

M_SRRM4_1_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Mice harboring a heterozygous frameshift deletion mutation spanning exons 7 and 8 of the SRRM4 gene. Heterozygous SRRM4 deletion mutant mice were crossed with Thy1-EGFP mouse line (PMID 11086982) to study dendritic spine density.
Allele Type: Targeted
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: Unreported
Mutant ES Cell Line: Unreported
Model Source: Unreported

M_SRRM4_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Targeted expression1
Decreased
Description: Srrm4 mutant mice with a homozygous deletion spanning exons 7 and 8, show negliglble expression of srrm4 protein compared to that in wildtype controls.
Exp Paradigm: Alpha tubulin is used as loading control.-western blot: cortex
 Western blot
 E18.5
Targeted expression1
Decreased
Description: Srrm4 mutant mice with a homozygous deletion spanning exons 7 and 8, show negliglble expression of srrm4 protein compared to that in wildtype controls.
Exp Paradigm: Alpha tubulin is used as loading control.- quantitative pcr (qrt-pcr)
 Quantitative pcr (qrt-pcr)
 E18.5
Gene expression: alternative splicing1
Abnormal
Description: Srrm4 mutant mice with a homozygous deletion spanning exons 7 and 8, show abnormal splicing of arvcf, ppfia2, slit2, dnm2, ptprd, synj1, dync2h1, pus7, vav2, itsn1, rapgef6, vps13c, nbea, shank1, smynd8, compared to wildtype controls. srrm4 mutant mice with a homozygous deletion spanning exons 7 and 8, show increased skipping of microexons in the forebrain as in activated neurons.
Exp Paradigm: Vast-tools software was used to detect and quantify alternative splicing from rna-seq data. number of alternative splicing events with percent spliced in (psi) was measured. neuronal activity dependent splicing of microexons was measured in mouse forebrain
 Rna sequencing
 E16.5, e18.5
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_SRRM4_1_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal number: interneurons1
Increased
Description: Srrm4 haploinsufficient mice show increased number of parvalbumin positive interneurons in the somatosensory cortex compared to wildtype controls.
Exp Paradigm: Pv
 Immunohistochemistry
 Adult
Dendritic architecture: spine density1
Increased
Description: Srrm4 haploinsufficient mice with the neuron specific thy1-egfp reporter show increase in the number of thin dendritic spines that lack the bulbous head characteristic of mature, functional spines, in the somatosensory cortex, compared to wildtype controls. mushroom, bulbous and filopodia dendritic spines show no change in number in srrm4 haploinsufficient mice compared to wildtype controls.
Exp Paradigm: Dendrites from layer v-vi pyramidal neurons in the somatosensory cortex were imaged from coronal slices. spines were counted on dendritic segments of approximately 35 microm.
 Confocal microscopy
 Adult
Electroretinogram (erg)1
Decreased
Description: Srrm4 haploinsufficient mice show slight decrease in amplitudes of a- and b- waves in erg recordings compared to wildtype controls.
Exp Paradigm: Reference electrode was inserted subcutaneously into the top of the head between the ears and eye electrodes rested on the corneas of each respective eye; b- and a-waves were measured from stimulations at 0.25 cd*s/m2 and 10 cd*s/m2.
 Electroretinogram (erg)
 12 weeks
Spontaneous post synaptic event frequency: excitatory currents1
Decreased
Description: Srrm4 haploinsufficient mice show decreased spontaneous excitatory epsp frequency compared to wildtype controls.
Exp Paradigm: Recordings were done on layer ii/iii pyramidal neurons of the somatosensory cortex in cortical slices placed in artificial cerebrospinal fluid.
 Whole-cell patch clamp
 Adult
Action potential property: firing rate1
Decreased
Description: Srrm4 haploinsufficient mice show decreased firing of evoked action potentials compared to wildtype controls.
Exp Paradigm: The number of action potentials recorded when applying increasing steps of current injections for 500 ms were quantified.
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: inhibitory1
Decreased
Description: Srrm4 haploinsufficient mice show decreased miniature inhibitory mipsp frequency compared to wildtype controls.
Exp Paradigm: Recordings were done on layer ii/iii pyramidal neurons of the somatosensory cortex in cortical slices placed in artificial cerebrospinal fluid.
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: excitatory1
Decreased
Description: Srrm4 haploinsufficient mice show decreased miniature excitatory epsp frequency compared to wildtype controls.
Exp Paradigm: Recordings were done on layer ii/iii pyramidal neurons of the somatosensory cortex in cortical slices placed in artificial cerebrospinal fluid.
 Whole-cell patch clamp
 Adult
Vision1
Decreased
Description: Srrm4 haploinsufficient mice show slight decrease in amplitudes of a- and b- waves in erg recordings compared to wildtype controls.
Exp Paradigm: Reference electrode was inserted subcutaneously into the top of the head between the ears and eye electrodes rested on the corneas of each respective eye; b- and a-waves were measured from stimulations at 0.25 cd*s/m2 and 10 cd*s/m2.
 Electroretinogram (erg)
 12 weeks
Startle response: acoustic stimulus1
Increased
Description: Srrm4 haploinsufficient mice show significant increase in the amplitude of the startle response and a decrease in the prepulse inhibition of the startle response, compared to wildtype controls, indicating sensory hypersensitivity.
Exp Paradigm: After an acclimation period of 5 minutes, mice were presented with 20 ms pre-pulses of varying intensities (70, 75, 80 and 85 db) alone or preceding a 120 db, 40-60 ms pulse by 50-120 ms.
 Prepulse inhibition
 Adult
Sensorimotor gating1
Decreased
Description: Srrm4 haploinsufficient mice show significant increase in the amplitude of the startle response and a decrease in the prepulse inhibition of the startle response, compared to wildtype controls, indicating sensory hypersensitivity.
Exp Paradigm: After an acclimation period of 5 minutes, mice were presented with 20 ms pre-pulses of varying intensities (70, 75, 80 and 85 db) alone or preceding a 120 db, 40-60 ms pulse by 50-120 ms.
 Prepulse inhibition
 Adult
Social approach1
Decreased
Description: Srrm4 haploinsufficient mice show a decrease in social approach measured by an increase in the time spent with an inanimate object over an unfamiliar mouse, compared to wildtype controls.
Exp Paradigm: Mice were given 10 min to interact with an object or a stranger mouse for the social choice test, followed by an additional 10 min to interact with a familiar mouse or a new stranger mouse for the social novelty test.
 Three-chamber social approach test
 Adult
Social memory1
Decreased
Description: Srrm4 haploinsufficient mice show a decrease in social memory, measured by the decrease in time spent with an unfamiliar mouse over a familiar mouse or neutral territory, compared to wildtype controls.
Exp Paradigm: Mice were given 10 min to interact with a familiar mouse or a new stranger mouse for the social novelty test. social novelty was measured by time spent in chamber with familiar mouse or in neutral chamber/time spent in chamber with stranger mouse.
 Three-chamber social approach test
 Adult
Social interaction1
Decreased
Description: Srrm4 haploinsufficient mice show a decrease in social interaction measured by nose to nose sniffing, compared to wildtype controls.
Exp Paradigm: Reciprocal interaction test was performed after at least 30 min of social isolation. mice unfamiliar to each other were allowed to interact for 10 min in a clean cage.
 Reciprocal social interaction test
 Adult
Targeted expression1
Decreased
Description: Srrm4 haploinsufficient mice show srrm4 transcript and protein expression at a level approaximately half of that in wildtype controls. srrm4 protein levels are reduced in response to neuronal activation. the protein undergoes proteasomal degradation.
Exp Paradigm: Alpha tubulin is used as loading control.-western blot
 Western blot
 E18.5
Targeted expression1
Decreased
Description: Srrm4 haploinsufficient mice show srrm4 transcript and protein expression at a level approaximately half of that in wildtype controls. srrm4 protein levels are reduced in response to neuronal activation. the protein undergoes proteasomal degradation.
Exp Paradigm: Alpha tubulin is used as loading control.- quantitative pcr (qrt-pcr): cortex
 Quantitative pcr (qrt-pcr)
 E18.5
Gene expression: alternative splicing1
Abnormal
Description: Srrm4 haploinsufficient mice show abnormal splicing of arvcf, ppfia2, slit2, dnm2, ptprd, synj1, dync2h1, pus7, vav2, itsn1, rapgef6, vps13c, nbea, shank1, smynd8, compared to wildtype controls.
Exp Paradigm: Vast-tools software was used to detect and quantify alternative splicing from rna-seq data. number of alternative splicing events with percent spliced in (psi) was measured.
 Rna sequencing
 E16.5
Anxiety1
 No change
 Elevated zero maze test
 Unreported
Anxiety1
 No change
 Light-dark exploration test
 Unreported
Exploratory activity: habituation1
 No change
 Open field test
 Unreported
Thigmotaxis1
 No change
 Open field test
 Unreported
Spatial working memory1
 No change
 Water y-maze test
 Unreported
General locomotor activity1
 No change
 Open field test
 Unreported
Membrane potential1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 Adult
Spontaneous post synaptic event amplitude: excitatory currents1
 No change
 Whole-cell patch clamp
 Adult
Spontaneous post synaptic event amplitude: inhibitory currents1
 No change
 Whole-cell patch clamp
 Adult
Spontaneous post synaptic event frequency: inhibitory currents1
 No change
 Whole-cell patch clamp
 Adult
Hearing1
 No change
 Auditory brainstem response test
 10 weeks
Olfaction1
 No change
 Olfactory discrimination test
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Maternal behavior, Physiological parameters, Repetitive behavior, Seizure


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
REST RE1-silencing transcription factor 5978 Q13127 CLIP; RNA immunoprecipitation (RIP)/qRT-PCR; ChIP-chip
Raj B , et al. 2011
Ahi1 Abelson helper integration site 1 52906 Q8K3E5 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Ank2 ankyrin 2, brain 109676 Q8C8R3 in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Ap2a1 adaptor protein complex AP-2, alpha 1 subunit 11771 P17426 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Arvcf armadillo repeat gene deleted in velo-cardio-facial syndrome 11877 P98203 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Asph aspartate-beta-hydroxylase 65973 Q8BSY0 CLIP; RNA immunoprecipitation (RIP)/qRT-PCR
Calarco JA , et al. 2009
Clasp1 CLIP associating protein 1 76707 Q80TV8 RNA-Seq; qRT-PCR; in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Clta clathrin, light polypeptide (Lca) 12757 O08585 RNA-Seq; qRT-PCR; in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Daam1 dishevelled associated activator of morphogenesis 1 208846 Q8BPM0 CLIP; RNA immunoprecipitation (RIP)/qRT-PCR
Calarco JA , et al. 2009
Dctn2 dynactin 2 69654 Q99KJ8 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Dock4 dedicator of cytokinesis 4 238130 P59764 CLIP; RNA immunoprecipitation (RIP)/qRT-PCR
Calarco JA , et al. 2009
Dync2h1 dynein cytoplasmic 2 heavy chain 1 110350 Q45VK7 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Elmo2 engulfment and cell motility 2, ced-12 homolog (C. elegans) 140579 Q8BHL5 CLIP; RNA immunoprecipitation (RIP)/qRT-PCR
Calarco JA , et al. 2009
Hook2 hook homolog 2 (Drosophila) 170833 Q7TMK6 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Itsn1 intersectin 1 (SH3 domain protein 1A) 16443 Q9Z0R4 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Mef2a myocyte enhancer factor 2A 17258 Q60929 in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Mon2 MON2 homolog (yeast) 67074 Q80TL7 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Nbea neurobeachin 26422 Q9EPN1 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Neo1 neogenin 18007 Q7TQG5 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Nrxn2 neurexin II 18190 E9Q7X7 in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Ppfia2 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 327814 Q8BSS9 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Pus7 pseudouridylate synthase 7 homolog (S. cerevisiae) 78697 B7ZNL8 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Rapgef6 Rap guanine nucleotide exchange factor (GEF) 6 192786 B2RUJ6 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Rest RE1-silencing transcription factor 19712 Q8VIG1 in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Shank1 SH3/ankyrin domain gene 1 243961 D3YZU1 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Slit2 slit homolog 2 (Drosophila) 20563 Q9R1B9 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Synj1 synaptojanin 1 104015 Q8CHC4 RNA-Seq; qRT-PCR; in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Taf1 TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor 270627 Q80UV9 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Tnrc6a trinucleotide repeat containing 6a 233833 Q3UHK8 in vivo splicing assay
Quesnel-Vallires M , et al. 2015
Unc13b unc-13 homolog B (C. elegans) 22249 Q9Z1N9 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Vav2 vav 2 oncogene 22325 Q60992 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Vps13c vacuolar protein sorting 13C (yeast) 320528 Q8BX70 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Zfyve27 zinc finger, FYVE domain containing 27 319740 Q3TXX3 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015
Zmynd8 zinc finger, MYND-type containing 8 228880 Q3U1M7 RNA-Seq; qRT-PCR
Quesnel-Vallires M , et al. 2015

HELP
Copyright © 2017 MindSpec, Inc.